Mrs Carmen B Diaz, PHD | |
2100 Ponce De Leon Blvd Ste 1015, Coral Gables, FL 33134-5240 | |
(786) 514-8812 | |
(305) 274-0692 |
Full Name | Mrs Carmen B Diaz |
---|---|
Gender | Female |
Speciality | Clinical Neuropsychologist |
Location | 2100 Ponce De Leon Blvd Ste 1015, Coral Gables, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134172505 | NPI | - | NPPES |
PY4145 | Other | FL | MEDICAL LICENSE # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | PY4145 (Florida) | Secondary |
103G00000X | Clinical Neuropsychologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Carmen B Diaz, PHD 9421 Sw 12th St, Miami, FL 33174-3027 Ph: (305) 485-1552 | Mrs Carmen B Diaz, PHD 2100 Ponce De Leon Blvd Ste 1015, Coral Gables, FL 33134-5240 Ph: (786) 514-8812 |
News Archive
Telehealth Solutions has today launched the CardioPod, a system to facilitate the new NHS Health Check nationwide. The CardioPod will be installed in pharmacies and GP surgeries across England, allowing patients easy access to an NHS Health Check carried out by a trained professional, who will give expert advice on their cardiovascular risk score and what action they can take to reduce the risk of heart disease, stroke, type II diabetes and kidney disease.
Commonly-prescribed opioid-based painkillers led to harmful side effects tripling in people with dementia.
Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.
NYU Langone Medical Center last month became the first hospital outside of a clinical trial site to implant a pacemaker-like device in the brain that may be a game-changer for patients with epilepsy.
› Verified 6 days ago